Toxins–Useful Biochemical Tools for Leukocyte Research by Cubillos, Susana et al.
Toxins 2010, 2, 428-452; doi:10.3390/toxins2040428 
 
toxins
ISSN 2072-6651 
www.mdpi.com/journal/toxins 
Review 
Toxins–Useful Biochemical Tools for Leukocyte Research 
Susana Cubillos, Johannes Norgauer * and Katja Lehmann  
Department of Dermatology, Medical School Jena, Erfurter Strasse 35, 07740, Jena, Germany;  
E-Mails: susana.cubillos@med.uni-jena.de (S.C.); katja.lehmann@med.uni-jena.de (K.L.) 
*  Author to whom correspondence should be addressed; E-Mail: johannes.norgauer@med.uni-
jena.de; Tel.: +049-364-193-7455; Fax: +049-364-193-7437. 
Received: 8 March 2010 / Accepted: 24 March 2010 / Published: 26 March 2010 
 
Abstract:  Leukocytes are a heterogeneous group of cells that display differences in 
anatomic localization, cell surface phenotype, and function. The different subtypes include 
e.g., granulocytes, monocytes, dendritic cells, T cells, B cells and NK cells. These different 
cell types represent the cellular component of innate and adaptive immunity. Using certain 
toxins such as pertussis toxin, cholera toxin or clostridium difficile toxin, the regulatory 
functions of Gαi, Gαs and small GTPases of the Rho family in leukocytes have been 
reported. A summary of these reports is discussed in this review. 
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1. Introduction  
Leukocytes are a heterogeneous group of cells that display differences in anatomic localization, cell 
surface phenotype, and function. They originate from CD34 bone marrow stem cells and progenitors 
of the different subtypes in the bone marrow. Finally, these progenitors or precursors circulate in the 
blood or are seeded via the bloodstream to the tissues where they give rise
 to highly specialized cells. 
The different subtypes include e.g., granulocytes (neutrophils, eosinophils, basophils), monocytes, 
dendritic cells, T cells, B cells and NK cells (Figure 1). These different cell types represent the cellular 
component of innate and adaptive immunity, protecting the body against invaders and functioning in 
tumor surveillance. Neutrophils, eosinophils and monocytes are cellular components of innate 
immunity and are involved in first line of defense against bacteria and helminth infections. Dendritic 
cells have the ability to take up antigens and readily degrade them in endocytic vesicles
 to produce 
antigenic peptides capable of binding major histocompatibility complex (MHC) class
 II. In response to 
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danger signals (i.e., tissue damage,
 pathogen-derived products, or inflammatory cytokines), dendritic 
cells migrate to lymphoid organs where they interact with CD4+ T cells to initiate specific immune 
responses. CD4+ T cells are involved in the development and clonal expansion of effector αβ T (e.g., 
CD8+ cytotoxic T cells) or B cells. NK cells attack cells that are missing "self" markers of MHC class 
I without prior activation: therefore, they play a major role in the rejection of tumors and cells infected 
by viruses. In contrast to αβ T cells, γδ T cells do not require antigen processing and MHC 
presentation of peptide epitopes for recognition of antigens. They are involved in defense against 
bacteria and in tumor surveillance. In order to fulfill all these different activities, the various subtypes 
of leukocytes perform highly specialized effector functions, summarized in Table 1. 
Figure 1. Differentiation diagram of CD34 bone marrow stem cells and progenitors into 
the different leukocytes subtypes. 
 
Table 1. The main specific functions of the leukocyte subtypes. 
Cell Type  Main functions 
Monocytes  Monocytes ingest antibodies or complement opsonized material by phagocytosis [1]. They are able to 
produce reactive oxygen species. Once activated, monocytes can present antigens to T cells and secrete 
cytokines such as IL-1, TNF-α, IL-6 and INF-α/β. They can express cell-adhesion molecules and 
migrate to inflammation sites by chemotaxis.  
Neutrophils  Neutrophils can express cell-adhesion molecules that allow diapedesis [2–4] and they can move to a site 
of infection or inflammation through a process called chemotaxis [5]. They can directly attack micro-
organisms by phagocytosis [6] and are able to produce reactive oxygen species [7], release soluble anti-
microbials and granule proteins (degranulation), and generate neutrophil extracellular traps (NETs) [8]. 
B Cells  B cells produce antibodies, which assist in the destruction of microbes by binding to them and making 
them easier targets for phagocytes and activation of the complement system, and eventually develop into 
memory B cells after activation by antigen interaction. 
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Table 1. Cont. 
αβ T Cells  T cells play a central role in cell-mediated immunity. There are several subgroups: 
T cells that express the CD4 protein on their surface are called T-helper cells because they assist B cells 
and cytotoxic T cells. T-helper cells recognize peptide antigens associated with MHC-class II on the 
surface of antigen presenting cells (APCs). Once activated, they divide rapidly and secrete cytokines 
that regulate the immune response.  
T cells that express the CD8 protein on their surface are called T-cytotoxic cells (CTLs) and can destroy 
virally infected cells and tumor cells with toxic granules, and are also implicated in transplant rejection.  
Memory T cells are a subset of antigen-specific T cells that persist long-term after an infection has 
resolved. They quickly expand to large numbers of effector T cells upon re-exposure to their cognate 
antigen, thus providing the immune system with "memory" against past infections. 
Regulatory T cells, formerly known as suppressor T cells, are crucial for the maintenance of 
immunological tolerance. Their major role is to regulate T cell-mediated immunity toward the end of an 
immune reaction and to suppress auto-reactive T cells that escaped the process of negative selection in 
the thymus. 
γδ T Cells  This small group of T cells possesses a distinct T cell receptor (TCR) on their surface. It seems that these 
cells are able to recognize whole proteins rather than requiring peptides to be presented by MHC 
molecules on APCs. 
γδ T cells utilize a variety of different mechanisms to regulate the inflammatory response. They secret 
cytokines and mediate inflammatory balance by inducing apoptosis in opposing cell populations 
(cytotoxicity). 
NK Cells  NK cells play a major role in the rejection of tumors and cells infected by viruses. The cells kill by 
releasing small cytoplasmic granules of proteins called perforins and granzymes. They can also kill 
target cells by mean of antibody dependent cell mediated cytotoxicity (ADCC). 
Dendritic 
Cells 
Upon activation, dendritic cells phagocyte and process antigens, migrate to lymph nodes to present the 
antigens to antigen-specific T cells and secrete various cytokines like IL-12 [9] and INF-γ [10] and 
chemokines that initiate and/or enhance many T and B lymphocyte responses.  
 
Recruitment of leukocytes from the circulation into inflammatory tissues or tumors requires a series 
of soluble and cell-bound interactions between the responding leukocyte and vascular endothelial 
barrier. Chemotactic factors are believed to be responsible for this selective adhesion and 
transmigration. A superfamily of small, soluble, structurally-related molecules called ‘chemokines’ has 
been identified and shown to selectively promote the rapid adhesion and chemotaxis of a variety of 
leukocyte subtypes both in vivo and in vitro. In addition, bacterial wall-derived peptides, lipids, 
complement fragments as well as micro-milleu components such as ATP, ADP, adenosine, spingosine-
1-phosphate, lysophospatidic acid, histamine and serotonin have chemotactic activity for   
certain subtypes. 
Most chemotaxins in leukocytes develop their biological activity by interactions with specific Gi 
protein-coupled serpentine receptors (GPCRs). The coupled guanine nucleotide-binding proteins   
(G proteins) represent a family of heterotrimeric proteins composed of α-,  β-, and γ subunits. In 
humans, there are at least 21 Gα subunits, 6 Gβ subunits and 12 Gγ subunits [11]. The α-subunits are 
further subdivided in αi, αs, αq and α12 subgroups. Recently, a fifth Gα protein, Gv, was discovered 
[12]. Heterotrimeric G proteins function as "molecular switches," alternating between an inactive 
guanosine diphosphate (GDP)- and active guanosine triphosphate (GTP)-bound state in order to Toxins 2010, 2                 
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regulate downstream signaling pathways and cell processes. They are activated in response to a 
conformation change in the G protein-coupled receptor after interactions with the specific ligands, 
followed by the exchange of GDP for GTP on the α-subunits. This results in the dissociation into 
active GTP-bound α-subunits and free βγ-dimers. These components again activate other proteins in 
signal transduction pathways. The Gαi subgroup is named in accordance to their inhibitory function on 
adenylylcyclase. Free βγ-subunits activate phospholipase Cβ2 [13]. This enzyme cleaves 
phosphatidylinositol (4,5)-bisphosphate (PIP2) to form two second-messenger molecules called 
inositol triphosphate (IP3) and diacylglycerol (DAG). The latter activates another enzyme called 
protein kinase C (PKC), and IP3 triggers the release of calcium from intracellular stores. Free   
βγ-subunits are also able to activate phosphatidylinositol-3-kinase-γ, which phosporylates PIP2 
generating PIP3. This lipid is able to interact with pleckstrin homology domains (PH-domains) on a 
broad spectrum of effector proteins such as proteins of the serine/threonine-specific protein kinase 
family AKT. Once correctly positioned in the membrane via binding of PIP3, Akt is phosphorylated on 
two
 key residues: T308 in the activation loop by PDK1 [14] and S473 in the hydrophobic motif of the  
C-terminal. The mammalian target of rapamycin complex 2 (mTORC2) acts as the long-sought PDK2 
molecule [15]. Phosphorylation by mTORC2 stimulates the subsequent phosphorylation of Akt by 
PDK1. Activated Akt can then go on to activate or deactivate its myriad substrates via its kinase 
activity. Besides being a downstream effector of PI 3-kinases, Akt may also be activated in a PI  
3-kinase-independent manner. Studies have suggested that cAMP-elevating agents could activate Akt 
through protein kinase A (PKA), although these studies are disputed and the mechanism of action is 
unclear. Akt regulates different cellular responses (e.g., cell proliferation, cell survival, and 
metabolism) by binding and regulating several downstream effectors. Akt can influence cell survival 
by regulating proapoptotic proteins like the BCL-2 family member BAD [16] or the indirect activation 
of nuclear factor κB (NF-κB) by regulating IκB kinase (IKK). Akt-mediated phosphorylation of p53-
specific E3 ubiquitin ligase (MDM2) results in degradation of p53. The inhibitory phophorylating of 
glycogen synthase kinase 3 (GSK-3) by Akt leads to promotion of glycogen synthesis. 
Aktivation of GPCR is also closely associated with the activation Rho family GTPases. Rho/Rac 
proteins constitute a subgroup of the Ras superfamily of GTP hydrolases. These proteins are classified 
into six subfamilies: Rho, Rac, Cdc42, Rnd, RhoBTB and RhoT/Miro. The ‘‘molecular switches’’ 
between the GDP- or GTP-bound state is controlled by two types of regulatory proteins GEFs and 
GAPs. GEFs induce the exchange of GDP for GTP molecules, promoting the activation of these 
proteins during signal transduction. The hydrolysis of the bound GTP molecules by GAPs, results in 
the transfer of the GTPase back to the inactive state. GEFs like P-Rex1 or SWAP70 can be activated 
by PIP3 since they contain the PH domain. The Rho/Rac-GTPases coordinate diverse cellular functions 
including cytoskeletal events, cell polarity, vesicular trafficking, cell cycle and transcriptomal 
dynamics. In leukocytes, Rho proteins are essential for epithelial barrier functions, immune cell 
migration, adhesion, phagocytosis, superoxide production, cytokine secretion and immune cell 
signaling. This functional diversity can be explained by the interaction of Rac/Rho proteins with many 
downstream effector molecules. To date, more than 70 potential effectors have been identified e.g., 
PAK1, Stat3, FlnA (reviewed in [17]). 
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2. Pertussis Toxin 
Pertussis toxin (PT) is a protein-based exotoxin produced by the bacterium Bordetella pertussis. It 
is involved in the colonization of bacteria in the respiratory tract and causes whooping cough. The 
exotoxin contains six subunits (named S1 through S5 - each complex contains two copies of S4). The 
subunits are arranged in an A-B structure: the A component is enzymatically active and is formed from 
the S1 subunit, while the B component is the receptor-binding portion and is made up of subunits  
S2–S5 [18]. 
PT is released from Bordetella pertussis in an inactive form. After binding to a cell membrane 
receptor, it is taken up in an endosome and retrograde transported to the trans-Golgi network and 
endoplasmic reticulum [19]. At some point during this transport, the A subunit becomes activated, 
presumably involving the action of glutathione and ATP. PT catalyzes the ADP-ribosylation of Gαi 
and Gαo subunits. This prevents the G proteins from interacting with G protein-coupled receptors on 
the cell membrane, interrupting intracellular communication. Since the Gα subunits remain in their 
GDP-bound and inactive state, they cannot inhibit adenylyl cyclase, thereby causing adenylyl cyclase 
to be inappropriately active and leading to increased cellular concentrations of cAMP within the cell. 
On the other hand, serpentine receptors interact probably in a very specific manner with a distinct 
composition of α-, β-, and γ-subunits. Therefore, participation of Gαi in specific receptor-mediated 
signaling can be also seen in βγ-regulated pathways (e.g., PLCβ or PI3Kγ) due to missing dissociation 
of the inactive heterotrimeric GDP-bound complex into free βγ-dimers. Using pertussis toxin as a tool, 
essential participation of Gαi in multiple cell responses and signaling pathways has been reported in 
leukocytes (Table 2). 
Table 2. Effect of pertussis toxin on different leukocyte functions. + is an increase or 
induction, - is an inhibition or decrease of different cell functions. 
Cell Type  Cell functions  Pertussis toxin 
Monocytes Phagocytosis 
Cytokine production 
Chemotaxis 
Migration 
+/- [27,28,44] 
+/- [20,23,31] 
- [21,22,24,30,33] 
+ [29,34] 
Neutrophils Cytotoxicity 
Phagocytosis 
Oxygen reactive species
Degranulation 
Migration 
Chemotaxis 
- [25] 
-[44,45] 
- [39,40–42,45] 
- [36] 
- [37,43] 
- [35,38,39,45] 
B Cells  Proliferation  
Activation 
Antibody production 
Migration 
+/- [49,51,55] 
- [50,53,54,56,57] 
- [51] 
- [46–48,52] 
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Table 2. Cont. 
αβ T Cells  Proliferation 
Cytokine production 
Migration 
Chemotaxis 
Th1 selection 
Th2 differentiation 
+ [32,60] 
+/- [60,65,71,72] 
- [61,64,69,70] 
- [58,62,67,69] 
+ [66] 
+ [59] 
γδ T Cells  Proliferation  + [68] 
NK Cells  Cytotoxicity 
Chemotaxis 
- [81] 
- [73–80,82–84] 
Dendritic 
Cells 
Antigen presentation 
Cytokine production 
Migration 
Chemotaxis 
- [89] 
- [26,88] 
- [85,86,89] 
- [63,87,90] 
3. Cholera Toxin 
Cholera toxin is an oligomeric protein complex secreted by Vibrio cholerae. It consits of six protein 
subunits: a single copy of the A subunit (part A), and five copies of the B subunit (part B). The two 
parts are connected by a disulfide bond. The five B subunits form a five-member ring. The A subunit 
has two important segments. The A1 portion of the chain is an ADP-ribosyltransferase for Gs proteins, 
while the alpha helix form of the A2 chain sits in the central pore of the B subunit ring [91]. 
Cholera toxin bound to GM1 gangliosides on the surface of cell is endocytosed, and transported  to 
the Golgi and the endoplasmatic reticulum as a holotoxin. At the endoplasmatic reticulum, a protein 
disulfide isomerase unfolds and cut the A1 fragment from the B subunits. Then, at least the A1 subunit 
is translocated into the cytosol via receptor-mediated endocytosis [92]. The free A subunit binds with a 
partner protein called ADP-ribosylation factor 6, driving a conformation change. Thereafter, the   
A-subunit catalyses ADP ribosylation from NAD to the Gαs subunit of heterotrimeric G protein, 
resulting in constitutive cAMP production of the regulatory component of adenylate cyclase. Increased 
adenylate cyclase activity results in elevated intracellular cyclic AMP (cAMP) production and levels. 
The pathophysiological consequence of intestinal infection or elevated cAMP levels is therefore 
secretion of H2O, Na
+, K
+, Cl
-, and HCO3
- into the lumen of the small intestine, resulting in rapid 
dehydration and diarrhea. Using cholera toxin as a tool, regulatory functions of Gαs proteins and 
adenylyl cylase in multiple cell responses has been reported in leukocytes (Table 3). 
Table 3. Effect of cholera toxin on different leukocyte functions. + is an increase or 
induction, - is an inhibition or decrease, ne means no effect, and the other are simply 
several Cholera toxin effects on different cell functions. 
Cell Type  Cell functions  Cholera toxin 
Monocytes Phagocytosis 
Cytokine production 
Oxygen reactive species 
Chemotaxis 
Migration 
-/ne [44,112,113] 
+/- [93,94,96–103,109–111] 
ne [108] 
ne [105–107] 
ne [104] Toxins 2010, 2                 
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Table 3. Cont. 
Neutrophils Phagocytosis 
Oxygen reactive species 
Degranulation 
Migration 
Chemotaxis 
-/ne [112,119,124,125] 
-/ne [116,117,120,121,123] 
ne [122,123,126] 
-/ne [114,115,126] 
- [118,127–129] 
B Cells  Proliferation  
Immunoglobulin production 
Memory cells 
+/- [131,135,148–150,173,179] 
+ [130,131,134–136,138,142–144,147,151,152,155,171] 
+ [133,141,146,153] 
αβ T Cells  Proliferation 
Activation 
Cytotoxicity 
Cytokine production 
Chemotaxis 
Th1 selection 
Th2 differentiation 
Tolerance or memory 
+/- [131,136,157,162,164,165,167,169,172,175,177–179,197] 
+/- [140,143,160,171–174,176] 
+ [174] 
+/- [72,78,96,101,154,156,160–164,172] 
- [183] 
- [95,101,159,161,165,166] 
+ [95,101,144,145,156,158,168,170] 
+ [132,146] 
NK Cells  Proliferation 
Activation 
Cytotoxicity 
Migration 
Chemotaxis 
- [139] 
- [181,185] 
- [81,182,184,186,187] 
- [180] 
- [83,84,181] 
Dendritic Cells  Activation 
Antigen presentation 
Cytokine production 
Migration 
+ [194–196,200] 
+ [191,197] 
+/- [93,101,161,189,190,192,194,196,199] 
+ [137,188,193,199] 
4. Toxin A and B 
Toxin A and Toxin B (TcdA and TcdB) are the major virulenz factors of Clostridium difficile. 
TcdA and Tcd B are exotoxins and belong to the family of clostridial glucosylation toxins. They are 
very large proteins with a molecular weight between 269 and 308 kDa and are characterized by a 
modular, tripartide composition [201]. The glucosyltransferase activity of the toxins is located in the 
N-terminal region. The hydrophobic region in the center of the protein is thought to be involved in the 
translocation of the toxin from the endosomes into the cytosol of the target cells. The receptor binding 
seems to be restricted to the C-terminal part.  
Clostridial glucosylating toxins enter eukaryotic target cells according to the ‘short trip model’ of 
bacterial exotoxin uptake [202]. After binding to the target cell, they are endocytosed. In the 
endosomal compartment, the toxin undergoes conformational changes allowing the insertion in the 
endosomal membrane and subsequent pore formation in a pH-dependent manner. After autocatalytical 
cleavage only the glucosytransferase domain of the N-terminus is released into the cytosol (reviewed 
by [203]). 
The intracellular target of TcdA and TcdB are small GTPases of the Rho family. The toxins modify 
Rho GTPases via mono-O-glycosylation at a threonine residue, which is located in the switch-I region 
[204]. TcdA and TcdB specifically glucosylate RAC, Cdc42 or Ras [203]. The functional consequence Toxins 2010, 2                 
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of the glucosylation is diverse, but it always causes the biological inactivity of the GTPases. The 
glucosylation blocks the activation of the GTPases by their activators (GEFs) and inhibits intrinsic and 
GAP-stimulated GTPase activity. The glucosylated Rho GTPase is not able to interact with GDI and is 
therefore located at the plasma membrane. The consequence of the glucosylation is the inhibition of 
the interaction with the effector proteins (kinases or adaptor proteins) with subsequent blocking of 
signal transduction pathways (Figure 2). In contrast to endogenous cytosolic mono-O-glucosylation, 
the glucosylation by TcdA and TcdB seems to be irreversible.  
Inactivation of the Rho proteins leads to drastic changes in eukaryotic cells. The actin cytoskeleton 
is largely redistributed, accompanied by shrinking, rounding and detachment of the target cells. Using 
TcdA and TcdB as a tool, several more cellular responses have been reported (Table 4). 
Figure 2. The glucosylation blocks (a) the activation of the GTPases by their activators 
(GEFs) and (b) inhibits intrinsic and GAP-stimulated GTPase activity. (c) The 
glucolsylated Rho GTPase is not able to interact with GDI and is therefore located at the 
plasma membrane. (d) The consequence of the glucosylation is the inhibition of the 
interaction with the effector proteins (kinases or adapter proteins) with subsequent blocking 
of signal transduction pathways.  
 
Table 4. Effect of Clostridium difficile Toxin A and Toxin B (TcdA and TcdB) on 
different leukocyte functions. + is an increase or induction, - is an inhibition or decrease, ne 
means no effect, and the other are several TcdA and TcdB reported effects on different cell 
functions. 
Cell Type  Cell functions  Clostridium difficile toxins A and B 
Monocytes Phagocytosis 
Cytokine production 
Migration 
ne [205,214] 
+ [206,208–210,212–215] 
- [207,211] 
Neutrophils Phagocytosis 
Oxygen reactive species 
Migration 
Chemotaxis 
-/ne [216,222] 
- [218,219] 
+ [209,212,213,219] 
- [220] 
αβ T Cells  Proliferation   - [221] 
NK Cells  Cytotoxicity  + [226] 
Dendritic Cells  Maturation 
Phagocytosis 
Migration 
+ [217] 
- [224,225] 
- [223] Toxins 2010, 2                 
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5. Conclusions 
Based on the literature using the toxins described here, Gi proteins are involved in processes like 
cytokine production, chemotaxis, degranulation and production of oxygen reactive species in 
leukocytes; also in the proliferation and antibody production of lymphocytes; and in the development 
of Th1/Th2 immunbalance. On the other hand, Gs proteins limit the cytotoxicity of NK cells, play a 
major role in Th1/Th2 balance and development of memory B cells. Finally, the glucosylation and 
blockade of the small GTPases of the Rho family affects several functions like chemotaxis and oxygen 
reactive species production of leukocytes, and the proliferation of lymphocytes. 
References and Notes 
1.  Geske, F.J.; Monks, J.; Lehman, L.; Fadok, V.A. The role of the macrophage in apoptosis: 
hunter, gatherer, and regulator. Int. J. Hematol. 2002, 76, 16–26. 
2.  Lawrence, M.B.; Springer, T.A. Leukocytes roll on a selectin at physiologic flow rates: 
distinction from and prerequisite for adhesion through integrins. Cell 1991, 65, 859–873. 
3.  Zimmerman, G.A.; Prescott, S.M.; McIntyre, T.M. Endothelial cell interactions with 
granulocytes: tethering and signaling molecules. Immunol. Today 1992, 13, 93–100. 
4.  Huber, A.R.; Kunkel, S.L.; Todd, R.F.; Weiss, S.J. Regulation of transendothelial neutrophil 
migration by endogenous interleukin-8. Science 1991, 254, 99–102. 
5.  Zigmond, S.H. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic 
factors. J. Cell Biol. 1977, 75, 606–616. 
6.  Hirschhorn, R.; Weissman, G. Isolation and properties of human leukocyte lyosomes in vitro. 
Proc. Soc. Exp. Biol. Med. 1965, 119, 36–38. 
7.  Klebanoff, S.J. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J. Bacteriol. 
1968, 95, 2131–2138. 
8.  Volker, B.; Reichard, U.; Goosmann, C.; Fauler, B.; Uhlemann, Y.; Weiss, D.S.; Weinrauch, Y.; 
Zychlinsky, A. "Neutrophil Extracellular Traps kill Bacteria”. Science 2004, 303, 1532–1535. 
9.  Reis e Sousa, C.; Hieny, S.; Scharton-Kersten, T.; Jankovic, D.; Charest, H.; Germain, R.N.; 
Sher, A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of 
interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 1997, 186, 
1819–1829. 
10.  Siega, F.P.; Kadowaki, N.; Shodell, M.; Fitzgerald-Bocarsly, P.A.; Shah, K.; Ho, S.; Antonenko, 
S.; Liu, Y.J. The nature of the principal type 1 interferon-producing cells in human blood. 
Science 1999, 284, 1835–1837. 
11.  Downes, G.B.; Gautam, N. The G protein subunit gene families. Genomics 1999, 62, 544–552. 
12.  Oka, Y.; Saraiva, L.R.; Kwan, Y.Y.; Korsching, S.I. The fifth class of Galpha proteins. Proc. 
Natl. Acad. Sci. USA 2009, 5, 1484–1489.  
13.  Bonacci, T.M.; Ghosh, M.; Malik, S.; Smrcka, A.V. Regulatory interactions between the amino 
terminus of G-protein beta gamma subunits and the catalytic domain of phospholipase Cbeta2. J. 
Biol. Chem. 2005, 280, 10174–10181. Toxins 2010, 2                 
 
 
437
14.  Scheid, M.P.; Marignani, P.A.; Woodgett, J.R. Multiple phosphoinositide 3-kinase-dependent 
steps in activation of protein kinase B. Mol. Cell Biol. 2002, 22, 6247–6260. 
15.  Sarbassov, D.D.; Guertin, D.A.; Ali, S.M.; Sabatini, D.M. Phosphorylation and regulation of 
Akt/PKB by the rictor-mTOR complex. Science 2005, 307, 1098–1101. 
16.  Datta, S.R.; Dudek, H.; Tao, X.; Masters, S.; Fu, H.; Gotoh, Y.; Greenberg, M.E. Akt 
phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 
1997, 91, 231–234. 
17.  Bustelo, X.R.; Sauzeau, V.; Berenjeno; I.M. GTP-binding proteins of the Rho/Rac family: 
regulation, effectors and functions in vivo. Bioessays 2007, 4, 356–370. 
18.  Stein, P.E.; Boodhoo, A.; Armstrong, G.D.; Cockle, S.A.; Klein, M.H.; Read, R.J. The crystal 
structure of pertussis toxin. Structure 1994, 1, 45–57. 
19.  Plaut, R.D.; Carbonetti, N.H. Retrograde transport of pertussis toxin in the mammalian cell. Cell 
Microbiol. 2008, 5, 1130–1139. 
20.  Schepetkin, I.A.; Kirpotina, L.N.; Tian, J.; Khlebnikov, A.I.; Ye, R.D.; Quinn, M.T. 
Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor 
necrosis factor alpha production. Mol. Pharmacol. 2008, 2, 392–402.  
21.  Park, K.S.; Lee, H.Y.; Lee, S.Y.; Kim, M.K.; Kim, S.D.; Kim, J.M.; Yun, J.; Im, D.S.; Bae, Y.S. 
Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in   
SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled 
receptor. FEBS Lett. 2007, 581, 4411–4416.  
22.  Leach, K.; Charlton, S.J.; Strange, P.G. Analysis of second messenger pathways stimulated by 
different chemokines acting at the chemokine receptor CCR5. Biochem. Pharmacol. 2007, 74, 
881–890.  
23.  Fan, H.; Williams, D.L.; Breuel, K.F.; Zingarelli, B.; Teti, G.; Tempel, G.E.; Halushka, P.V.; 
Cook, J.A. Gi proteins regulate lipopolysaccharide and Staphylococcus aureus induced cytokine 
production but not (1-3)-beta-D-glucan induced cytokine suppression. Front. Biosci. 2006, 11, 
2264–2274. 
24.  Musso, T.; Cappello, P.; Stornello, S.; Ravarino, D.; Caorsi, C.; Otero, K.; Novelli, F.; Badolato, 
R.; Giovarelli, M. IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human 
monocytes. Int. J. Immunopathol. Pharmacol. 2005, 18, 339–349. 
25.  Bellner, L.; Thorén, F.; Nygren, E.; Liljeqvist, J.A.; Karlsson, A.; Eriksson, K. A 
proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, 
monocyte, and NK cell functions. J. Immunol. 2005, 174, 2235–2241. 
26.  Idzko, M.; Panther, E.; Sorichter, S.; Herouy, Y.; Berod, L.; Geissler, M.; Mockenhaupt, M.; 
Elsner, P.; Girolomoni, G.; Norgauer, J. Characterization of the biological activities of uridine 
diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release. J. Cell. 
Physiol. 2004, 201, 286–293. 
27.  Schaeffer, L.M.; Weiss, A.A. Pertussis toxin and lipopolysaccharide influence phagocytosis of 
Bordetella pertussis by human monocytes. Infect. Immun. 2001, 69, 7635–7641. 
28.  Boschwitz, J.S.; Batanghari, J.W.; Kedem, H.; Relman, D.A. Bordetella pertussis infection of 
human monocytes inhibits antigen-dependent CD4 T cell proliferation. J. Infect. Dis. 1997, 176, 
678–686. Toxins 2010, 2                 
 
 
438
29.  Wong, W.S.; Luk, J.M. Signaling mechanisms of pertussis toxin-induced myelomonocytic cell 
adhesion: role of tyrosine phosphorylation. Biochem. Biophys. Res. Commun.  1997,  236,  
479–482. 
30.  Schratzberger, P.; Wöll, E.; Reinisch, N.; Kähler, C.M.; Wiedermann, C.J. Secretoneurin-
induced in vitro chemotaxis of human monocytes is inhibited by pertussis toxin and an inhibitor 
of protein kinase C. Neurosci. Lett. 1996, 214, 208–210. 
31.  Torre, D.; Pugliese, A.; Tambini, R.; Speranza, F.; Zeroli, C. Production and release of tumor 
necrosis factor alfa, interleukin-1B and interleukin-6 by human mononuclear leukocytes 
stimulated with pertussis toxin. New Microbiol. 1993, 16, 309–314. 
32.  Grenier-Brossette, N.; Bourget, I.; Breittmayer, J.P.; Ferrua, B.; Fehlmann, M.; Cousin, J.L. 
Pertussis toxin-induced mitogenesis in human T lymphocytes. Immunopharmacology 1991, 21, 
109–119. 
33.  Verghese, M.; Uhing, R.J.; Snyderman, R. A pertussis/choleratoxin-sensitive N protein may 
mediate chemoattractant receptor signal transduction. Biochem. Biophys. Res. Commun. 1986, 
138, 887–894. 
34.  Meade, B.D.; Kind, P.D.; Manclark, C.R. Lymphocytosis-promoting factor of Bordetella 
pertussis alters mononuclear phagocyte circulation and response to inflammation. Infect. Immun. 
1984, 46, 733–739. 
35.  Mariano-Oliveira, A.; De Freitas, M.S.; Monteiro, R.Q.; Barja-Fidalgo, C. Prothrombin 
fragments containing kringle domains induce migration and activation of human neutrophils. Int 
J. Biochem. Cell. Biol. 2008, 40, 517–529. 
36.  Frasch, S.C.; Zemski-Berry, K.; Murphy, R.C.; Borregaard, N.; Henson, P.M.; Bratton, D.L. 
Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce 
redundant signaling through G2A. J. Immunol. 2007, 178, 6540–6548. 
37.  Lokuta, M.A.; Nuzzi, P.A.; Huttenlocher, A. Calpain regulates neutrophil chemotaxis. Proc. 
Natl. Acad. Sci. USA 2003, 100, 4006–4011. 
38.  Chakraborty, A.; Hentzen, E.R.; Seo, S.M.; Smith, C.W. Granulocyte colony-stimulating factor 
promotes adhesion of neutrophils. Am. J. Physiol. Cell. Physiol. 2003, 284, C103–C110. 
39.  Berger, M.; Budhu, S.; Lu, E.; Li, Y.; Loike, D.; Silverstein, S.C.; Loike, J.D. Different   
G(i)-coupled chemoattractant receptors signal qualitatively different functions in human 
neutrophils. J. Leukoc. Biol. 2002, 71, 798–806. 
40.  Lärfars, G.; Gyllenhammar, H. Stimulus-dependent transduction mechanisms for nitric oxide 
release in human polymorphonuclear neutrophil leukocytes. J. Lab. Clin. Med. 1998, 132, 54–60. 
41.  Rossi, M.A.; Di Mauro, C.; Dianzani, M.U. Action of lipid peroxidation products on 
phosphoinositide specific phospholipase C. Mol. Aspects Med. 1993, 14, 273–279. 
42.  Balazovich, K.J.; Almeida, H.I.; Boxer, L.A. Recombinant human G-CSF and GM-CSF prime 
human neutrophils for superoxide production through different signal transduction mechanisms. 
J. Lab. Clin. Med. 1991, 118, 576–584. 
43.  Bengtsson, T. Correlation between chemotactic peptide-induced changes in chlorotetracycline 
fluorescence and F-actin content in human neutrophils: a role for membrane-associated calcium 
in the regulation of actin polymerization? Exp. Cell Res. 1990, 191, 57–63. Toxins 2010, 2                 
 
 
439
44.  Brown, E.J.; Newell, A.M.; Gresham, H.D. Molecular regulation of phagocyte function. 
Evidence for involvement of a guanosine triphosphate-binding protein in opsonin-mediated 
phagocytosis by monocytes. J. Immunol. 1987, 139, 3777–3782. 
45.  Lad, P.M.; Olson, C.V.; Smiley, P.A. Association of the N-formyl-Met-Leu-Phe receptor in 
human neutrophils with a GTP-binding protein sensitive to pertussis toxin. Proc. Natl. Acad. Sci. 
USA 1985, 82, 869–873. 
46.  Rieken, S.; Herroeder, S.; Sassmann, A.; Wallenwein, B.; Moers, A.; Offermanns, S.; 
Wettschureck, N. Lysophospholipids control integrin-dependent adhesion in splenic B cells 
through G(i) and G(12)/G(13) family G-proteins but not through G(q)/G(11). J. Biol. Chem. 
2006, 281, 36985–36992. 
47.  Itakura, A.; Szczepanik, M.; Campos, R.A.; Paliwal, V.; Majewska, M.; Matsuda, H.; Takatsu, 
K.; Askenase, P.W. An hour after immunization peritoneal B-1 cells are activated to migrate to 
lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of 
contact sensitivity. J. Immunol. 2005, 175, 7170–7178. 
48.  Lo, C.G.; Lu, T.T.; Cyster, J.G. Integrin-dependence of lymphocyte entry into the splenic white 
pulp. J. Exp. Med. 2003, 197, 353–361. 
49.  Deehan, M.R.; Klaus, G.G.; Holman, M.J.; Harnett, W.; Harnett, M.M. MAP-kinase: a second 
site of G-protein regulation of B-cell activation via the antigen receptors. Immunology 1998, 95, 
169–177. 
50.  Rosskopf, D.; Daelman, W.; Busch, S.; Schurks, M.; Hartung, K.; Kribben, A.; Michel, M.C.; 
Siffert, W. Growth factor-like action of lysophosphatidic acid on human B lymphoblasts. Am. J. 
Physiol. 1998, 274, C1573–C1582. 
51.  Huang, R.; Cioffi, J.; Kimberly, R.; Edberg, J.; Mayer, L. B cell differentiation factor-induced 
human B cell maturation: stimulation of intracellular calcium release. Cell. Immunol. 1995, 164, 
227–233. 
52.  Cyster, J.G.; Goodnow, C.C. Pertussis toxin inhibits migration of B and T lymphocytes into 
splenic white pulp cords. J. Exp. Med. 1995, 182, 581–586. 
53.  Huang, R.; Cioffi, J.; Berg, K.; London, R.; Cidon, M.; Maayani, S.; Mayer, L. B cell 
differentiation factor-induced B cell maturation: regulation via reduction in cAMP. Cell. 
Immunol. 1995, 162, 49–55. 
54.  Melamed, I.; Wang, G.; Roifman, C.M. Antigen receptor-mediated protein tyrosine kinase 
activity is regulated by a pertussis toxin-sensitive G protein. J. Immunol. 1992, 149, 169–174. 
55.  Kolb, J.P.; Genot, E.; Petit-Koskas ,E.; Paul-Eugene, N.; Dugas, B. Effect of bacterial toxins on 
human B cell activation. I. Mitogenic activity of pertussis toxin. Eur. J. Immunol. 1990, 20,  
969–976. 
56.  Dziarski, R. Correlation between ribosylation of pertussis toxin substrates and inhibition of 
peptidoglycan-, muramyl dipeptide- and lipopolysaccharide-induced mitogenic stimulation in B 
lymphocytes. Eur. J. Immunol. 1989, 1, 125–130. 
57.  Jakway, J.P.; DeFranco, A.L. Pertussis toxin inhibition of B cell and macrophage responses to 
bacterial lipopolysaccharide. Science 1986, 234, 743–746. 
58.  Schneider, O.D.; Weiss, A.A.; Miller, W.E. Pertussis toxin signals through the TCR to initiate 
cross-desensitization of the chemokine receptor CXCR4. J. Immunol. 2009, 182, 5730–5739. Toxins 2010, 2                 
 
 
440
59.  Rossi-Paccani, S.; Benagiano, M.; Capitani, N.; Zornetta, I.; Ladant, D.; Montecucco, C.; 
D'Elios, M.M.; Baldari C.T. The adenylate cyclase toxins of Bacillus anthracis and Bordetella 
pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. PLoS 
Pathog. 2009, 5, e1000325. 
60.  Schneider, O.D.; Weiss, A.A.; Miller, W.E. Pertussis toxin utilizes proximal components of the 
T-cell receptor complex to initiate signal transduction events in T cells. Infect. Immun. 2007, 75, 
4040–4049.  
61.  Matsuyuki, H.; Maeda, Y.; Yano, K.; Sugahara, K.; Chiba, K.; Kohno, T.; Igarashi, Y. 
Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response 
of mouse T cells toward S1P. Cell. Mol. Immunol. 2006, 3, 429–437. 
62.  Smit, M.J.; Verdijk, P.; van der Raaij-Helmer, E.M.; Navis, M.; Hensbergen, P.J.; Leurs, R.; 
Tensen, C.P. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and 
phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-
3 kinase. Blood 2003, 102, 1959–1965. 
63.  Panther, E.; Idzko, M.; Corinti, S.; Ferrari, D.; Herouy, Y.; Mockenhaupt, M.; Dichmann, S.; 
Gebicke-Haerter, P.; Di Virgilio, F.; Girolomoni, G.; Norgauer, J. The influence of 
lysophosphatidic acid on the functions of human dendritic cells. J. Immunol.  2002,  169,  
4129–4135. 
64.  Adamson, P.; Wilbourn, B.; Etienne-Manneville, S.; Calder, V.; Beraud, E.; Milligan, G.; 
Couraud, P.O.; Greenwood, J. Lymphocyte trafficking through the blood-brain barrier is 
dependent on endothelial cell heterotrimeric G-protein signaling. FASEB J.  2002,  16,  
1185–1194. 
65.  Nanki, T.; Lipsky, P.E. Stimulation of T-Cell activation by CXCL12/stromal cell derived factor-
1 involves a G-protein mediated signaling pathway. Cell. Immunol. 2001, 214, 145–154. 
66.  He, J.; Gurunathan, S.; Iwasaki, A.; Ash-Shaheed, B.; Kelsall, B.L. Primary role for Gi protein 
signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 
responses. J. Exp. Med. 2000, 191, 1605–1610. 
67.  Sotsios, Y.; Whittaker, G.C.; Westwick, J.; Ward, S.G. The CXC chemokine stromal cell-derived 
factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J. Immunol. 1999, 
163, 5954–5963. 
68.  Zorzeto, T.Q.; Hihashi, H.G.; da Silva, M.T.; Carniel Ede, F.; Dias, W.O.; Ramalho, V.D.; 
Mazzola, T.N.; Lima, S.C.; Morcillo, A.M.; Stephano, M.A.; Antonio, M.A.; Zanolli, M.d.L.; 
Raw, I.; Vilela, M.M. Immunogenicity of a whole cell pertussis vaccine with lipopolysaccharide 
content in infants. Clin. Vaccine Immunol. 2009, 16, 544–550. 
69.  del Pozo, M.A.; Sánchez-Mateos, P.; Nieto, M.; Sánchez-Madrid, F. Chemokines regulate 
cellular polarization and adhesion receptor redistribution during lymphocyte interaction with 
endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J. Cell. Biol. 
1995, 131, 495–508.  
70.  Chaffin, K.E.; Perlmutter, R.M. A pertussis toxin-sensitive process controls thymocyte 
emigration. Eur. J. Immunol. 1991, 144, 2565–2573. 
71.  Stanley, J.B.; Gorczynski, R.M.; Delovitch, T.L.; Mills, G.B. IL-2 secretion is pertussis toxin 
sensitive in a T lymphocyte hybridoma. J. Immunol. 1989, 142, 3546–3552. Toxins 2010, 2                 
 
 
441
72.  Gilmore, W.; Weiner, L.P. The effects of pertussis toxin and cholera toxin on mitogen-induced 
interleukin-2 production: evidence for G protein involvement in signal transduction. Cell. 
Immunol. 1988, 113, 235–250. 
73.  Kim, S.D.; Kim, J.M.; Jo, S.H.; Lee, H.Y.; Lee, S.Y.; Shim, J.W.; Seo, S.K.; Yun, J.; Bae, 
Y.S..Functional expression of formyl peptide receptor family in human NK cells. J. Immunol. 
2009, 183, 5511–5517. 
74.  Starnes, T.; Rasila, K.K.; Robertson, M.J.; Brahmi, Z.; Dahl, R.; Christopherson, K.; Hromas, R. 
The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the 
downregulation of CXCL14 in malignancy. Exp. Hematol. 2006, 34, 1101–1105. 
75.  Dagan-Berger, M.; Feniger-Barish, R.; Avniel, S.; Wald, H.; Galun, E.; Grabovsky, V.; Alon, R.; 
Nagler, A.; Ben-Baruch, A.; Peled, A. Role of CXCR3 carboxyl terminus and third intracellular 
loop in receptor-mediated migration, adhesion and internalization in response to CXCL11. Blood 
2006, 107, 3821–3831. 
76.  Jin, Y.; Knudsen, E.; Wang, L.; Maghazachi, A.A. Lysophosphatidic acid induces human natural 
killer cell chemotaxis and intracellular calcium mobilization. Eur. J. Immunol.  2003,  33,  
2083–2089. 
77.  Kveberg, L.; Bryceson, Y.; Inngjerdingen, M.; Rolstad, B.; Maghazachi, A.A. Sphingosine 1 
phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G 
proteins and phosphoinositide 3 kinases. Eur. J. Immunol. 2002, 32, 1856–1864. 
78.  Inngjerdingen, M.; Damaj, B.; Maghazachi, A.A. Human NK cells express CC chemokine 
receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-
derived chemokine, and I-309. J. Immunol. 2000, 164, 4048–4054. 
79.  Imai, T.; Hieshima, K.; Haskell, C.; Baba, M.; Nagira, M.; Nishimura, M.; Kakizaki, M.; Takagi, 
S.; Nomiyama, H.; Schall, TJ.; Yoshie, O. Identification and molecular characterization of 
fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997, 
91, 521–530. 
80.  Maghazachi, A.A.; Skalhegg, B.S.; Rolstad, B.; Al-Aoukaty, A. Interferon-inducible protein-10 
and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural 
killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J. 
1997, 11, 765–774. 
81.  Maghazachi, A.A.; Al-Aoukaty, A.; Naper, C.; Torgersen, K.M.; Rolstad, B. Preferential 
involvement of Go and Gz proteins in mediating rat natural killer cell lysis of allogeneic and 
tumor target cells. J. Immunol. 1996, 157, 5308–5314. 
82.  Allavena, P.; Bianchi, G.; Zhou, D.; van Damme, J.; Jílek, P.; Sozzani, S.; Mantovani, A. 
Induction of natural killer cell migration by monocyte chemotactic protein-1; -2 and -3. Eur. J. 
Immunol. 1994, 24, 3233–3236. 
83.  Maghazachi, A.A.; al-Aoukaty, A.; Schall, T.J. C-C chemokines induce the chemotaxis of NK 
and IL-2-activated NK cells. Role for G proteins. J. Immunol. 1994, 153, 4969–4977. 
84.  Sebok, K.; Woodside, D.; al-Aoukaty, A.; Ho, A.D.; Gluck, S.; Maghazachi, A.A. IL-8 induces 
the locomotion of human IL-2-activated natural killer cells. Involvement of a guanine nucleotide 
binding (Go) protein. J. Immunol. 1993, 150, 1524–1534. Toxins 2010, 2                 
 
 
442
85.  Salogni, L.; Musso, T.; Bosisio, D.; Mirolo, M.; Jala, V.R.; Haribabu, B.; Locati, M.; Sozzani, S. 
Activin A induces dendritic cell migration through the polarized release of CXC chemokine 
ligands 12 and 14. Blood 2009, 113, 5848–5856.  
86.  Lambert, H.; Hitziger, N.; Dellacasa, I.; Svensson, M.; Barragan, A. Induction of dendritic cell 
migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell. Microbiol. 
2006, 8, 1611–1623. 
87.  Shin, E.H.; Lee, H.Y.; Bae, Y.S. Leukotriene B4 stimulates human monocyte-derived dendritic 
cell chemotaxis. Biochem. Biophys. Res. Commun. 2006, 348, 606–611. 
88.  Oz-Arslan, D.; Rüscher, W.; Myrtek, D.; Ziemer, M.; Jin, Y.; Damaj, B.B.; Sorichter, S.; Idzko, 
M.; Norgauer, J.; Maghazachi, A.A. IL-6 and IL-8 release is mediated via multiple signaling 
pathways after stimulating dendritic cells with lysophospholipids.  J. Leukoc. Biol.  2006,  80,  
287–297. 
89.  Idzko, M.; Dichmann, S.; Ferrari, D.; Di Virgilio, F.; la Sala, A.; Girolomoni, G.; Panther, E.; 
Norgauer, J. Nucleotides induce chemotaxis and actin polymerization in immature but not mature 
human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 2002, 100, 
925–932. 
90.  Idzko, M.; Panther E.; Corinti S.; Morelli, A.; Ferrari, D.; Herouy, Y.; Dichmann, S.; 
Mockenhaupt, M.; Gebicke-Haerter, P.; Di Virgilio, F.; Girolomoni, G.; Norgauer, J. 
Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in 
mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 2002, 16,  
625–627. 
91.  Merritt, E.A.; Sarfaty, S.; van den Akker, F.; L'Hoir, C.; Martial, J.A.; Hol, W.G. Crystal 
structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Protein Sci. 1994, 
3, 166–175. 
92.  Fujinaga, Y. Transport of bacterial toxins into target cells: pathways followed by cholera toxin 
and botulinum progenitor toxin. J. Biochem. 2006, 2, 155–160. 
93.  la Sala, A.; He, J.; Laricchia-Robbio, L.; Gorini, S.; Iwasaki, A.; Braun, M.; Yap, G..; Sher, A.; 
Ozato, K.; Kelsall, B. Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell 
differentiation by cAMP-mediated inhibition of IRF8 function. J. Exp. Med.  2009,  206,  
1227–1235. 
94.  Domingos, M.O; Andrade, R.G.; Barbaro, K.C.; Borges, M.M.; Lewis, D.J.; New, R.R. Influence 
of the A and B subunits of cholera toxin (CT) and Escherichia coli toxin (LT) on TNF-alpha 
release from macrophages. Toxicon 2009, 53, 570–577. 
95.  Royaee, A.R.; Mendis, C.; Das, R.; Jett, M.; Yang, D.C. Cholera toxin induced gene expression 
alterations. Mol. Immunol. 2006, 43, 702–709. 
96.  Royaee, A.R.; Hammamieh, R.; Mendis, C.; Das, R.; Jett, M.; Yang, D.C.H. Induction of 
immunomodulator transcriptional responses by cholera toxin. Mol. Immunol.  2006,  43,  
1020–1028.  
97.  Burkart, V.; Kim, Y.E.; Hartmann, B.; Ghiea, I.; Syldath, U.; Kauer, M.; Fingberg, W.; Hanifi-
Moghaddam, P.; Müller, S.; Kolb, H. Cholera toxin B pretreatment of macrophages and 
monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide. J. Immunol. 
2002, 168, 1730–1737. Toxins 2010, 2                 
 
 
443
98.  Seldon, P.M.; Giembycz, M.A. Suppression of granulocyte/macrophage colony-stimulating 
factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10. Br. 
J. Pharmacol. 2001, 134, 58–67. 
99.  Burkart, V.; Kim, Y.; Kauer, M.; Kolb, H. Induction of tolerance in macrophages by cholera 
toxin B chain. Pathobiology 1999, 67, 314–317. 
100.  Yan, Z.; Yang, D.C.; Jett, M. Cholera toxin induces tumor necrosis factor alpha production in 
human monocytes. Mol. Cell. Biol. Res. Commun. 1999, 2, 124–130. 
101.  Braun, M.C.; He, J.; Wu, C.Y.; Kelsall, B.L. Cholera toxin suppresses interleukin (IL)-12 
production and IL-12 receptor beta1 and beta2 chain expression. J. Exp. Med.  1999,  189,  
541–552. 
102.  López-Zabalza, M.J.; Martínez-Lausín, S.; Bengoechea-Alonso, M.T.; López-Moratalla, N.; 
González, A.; Santiago, E. Signaling pathway triggered by a short immunomodulating peptide on 
human monocytes. Arch. Biochem. Biophys. 1997, 338, 136–142. 
103.  Mattsson, E.; Van Dijk, H.; Van Kessel, K.; Verhoef, J.; Fleer, A.; Rollof, J..Intracellular 
pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation 
with lipopolysaccharide or staphylococcal peptidoglycan are partly similar. J. Infect. Dis. 1996, 
173, 212–218. 
104.  Zhou, D.; Luini, W.; Bernasconi, S.; Diomede, L.; Salmona, M.; Mantovani, A.; Sozzani, S. 
Phosphatidic acid and lysophosphatidic acid induce haptotactic migration of human monocytes. 
J. Biol. Chem. 1995, 270, 25549–25556. 
105.  Badolato, R.; Johnston, J.A.; Wang, J.M.; McVicar, D.; Xu, L.L.; Oppenheim, J.J.; Kelvin, D.J. 
Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by 
activating a pertussis toxin-sensitive signaling pathway. J. Immunol. 1995, 155, 4004–4010. 
106.  Mansfield, P.J.; Suchard, S.J. Thrombospondin promotes chemotaxis and haptotaxis of human 
peripheral blood monocytes. J. Immunol. 1994, 153, 4219–4229. 
107.  Sozzani, S.; Zhou, D.; Locati, M.; Rieppi, M.; Proost, P.; Magazin, M.; Vita, N.; van Damme, J.; 
Mantovani, A. Receptors and transduction pathways for monocyte chemotactic protein-2 and 
monocyte chemotactic protein-3. Similarities and differences with MCP-1. J. Immunol. 1994, 
152, 3615–3622. 
108.  Puri, J.; Taplits, M.; Alava, M.; Bonvini, E.; Hoffman, T. Inhibition of release of arachidonic 
acid, superoxide and IL-1 from human monocytes by monoclonal anti-HLA class II antibodies: 
effects at proximal and distal points of inositol phospholipid hydrolysis pathway. Inflammation 
1992, 16, 31–44. 
109.  Sung, S.S.; Walters, J.A. Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA 
expression and protein production in human myelomonocytic cell lines and monocytes. J. Clin. 
Invest. 1991, 88, 1915–1923. 
110.  Vellenga, E.; van der Vinne, B.; De Wolf, J.T.; Halie, M.R. Simultaneous expression and 
regulation of G-CSF and IL-6 mRNA in adherent human monocytes and fibroblasts. Br. J. 
Haematol. 1991, 78, 14–18. 
111.  Kassis, S.; Lee, J.C.; Hanna, N. Effects of prostaglandins and cAMP levels on monocyte IL-1 
production. Agents Actions 1989, 27, 274–276. Toxins 2010, 2                 
 
 
444
112.  Yang, K.D.; Augustine, N.H.; Shaio, M.F.; Bohnsack, J.F.; Hill H.R. Effects of fibronectin on 
actin organization and respiratory burst activity in neutrophils, monocytes, and macrophages. J. 
Cell. Physiol. 1994, 158, 347–353. 
113.  O'Dorisio, M.S.; Vandenbark, G.R.; LoBuglio, A.F. Human monocyte killing of Staphylococcus 
aureus: modulation by agonists of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 
3',5'-monophosphate. Infect. Immun. 1979, 26, 604–610. 
114.  Viana, C.F.; Melo, D.H.; Carneiro-Filho, B.A.; Michelin, M.A.; Brito, G.A.; Cunha, F.Q.; Lima, 
AA.; Ribeiro, R.A. Pro-inflammatory effects of cholera toxin: role of tumor necrosis factor 
alpha. Toxicon 2002, 40, 1487–1494. 
115.  Garcia, J.G.; Verin, A.D.; Herenyiova, M.; English, D. Adherent neutrophils activate endothelial 
myosin light chain kinase: role in transendothelial migration. J. Appl. Physiol.  1998,  84,  
1817–1821. 
116.  Tithof, P.K.; Watts, S.; Ganey, P.E. Protein tyrosine kinase involvement in the production of 
superoxide anion by neutrophils exposed to Aroclor 1242, a mixture of polychlorinated 
biphenyls. Biochem. Pharmacol. 1997, 53, 1833–1842. 
117.  Carreras, M.C.; Riobó N.A.; Pargament G.A.; Boveris, A.; Poderoso, J.J. Effects of respiratory 
burst inhibitors on nitric oxide production by human neutrophils. Free Radic. Res. 1997, 26, 
325–334. 
118.  Suchard, S.J.; Mansfield, P.J. Neutrophil thrombospondin receptors are linked to GTP-binding 
proteins. J. Cell. Physiol. 1996, 168, 217–227. 
119.  Jin, G.F.; Guo, Y.S.; Ball, C.; Houston, C.W. Insulin-like growth factors enhance phagocytosis 
by human neutrophils in vitro. Regul. Pept. 1993, 49, 125–131. 
120.  Braquet, P.; Hosford, D.; Koltz, P.; Guilbaud, J.; Paubert-Braquet, M. Effect of platelet-
activating factor on tumor necrosis factor-induced superoxide generation from human 
neutrophils. Possible involvement of G proteins. Lipids 1991, 26, 1071–1075. 
121.  Paubert-Braquet, M.; Hosford, D.; Klotz, P.; Guilbaud, J.; Braquet, P. Tumor necrosis factor 
alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: 
possible involvement of G proteins. J. Lipid Mediat. 1990, 2 Suppl., S1–S4. 
122.  Gabler, W.L.; Creamer, H.R.; Bullock, W.W. Fluoride activation of neutrophils: similarities to 
formylmethionyl-leucyl-phenylalanine. Inflammation 1989, 13, 47–58. 
123.  Blackburn, W.D Jr.; Heck, L.W. Neutrophil activation by surface bound IgG: pertussis toxin 
insensitive activation. Biochem. Biophys. Res. Commun. 1988, 152, 136–142. 
124.  Gresham, H.D.; Clement, L.T.; Volanakis, J.E.; Brown, E.J. Cholera toxin and pertussis toxin 
regulate the Fc receptor-mediated phagocytic response of human neutrophils in a manner 
analogous to regulation by monoclonal antibody 1C2. J. Immunol. 1987, 139, 4159–4166. 
125.  Lad, P.M.; Olson, C.V.; Grewal, I.S. A step sensitive to pertussis toxin and phorbol ester in 
human neutrophils regulates chemotaxis and capping but not phagocytosis. FEBS Lett. 1986, 
200, 91–96. 
126.  Shefcyk, J.; Yassin, R.; Volpi, M.; Molski, T.F.; Naccache, P.H.; Munoz, J.J.; Becker, E.L.; 
Feinstein, M.B.; Sha'afi, R.I. Pertussis but not cholera toxin inhibits the stimulated increase in 
actin association with the cytoskeleton in rabbit neutrophils: role of the "G proteins" in stimulus-
response coupling. Biochem. Biophys. Res. Commun. 1985, 126, 1174–1181. Toxins 2010, 2                 
 
 
445
127.  Roch-Arveiller, M.; Boquet, P.; Bradshaw, D.; Giroud, J.P. Inhibition by cholera toxin of rat 
polymorphonuclear leukocyte chemotaxis demonstrated in vitro and in vivo. Infect. Immun. 1979, 
25, 187–190. 
128.  Issekutz, A.C.; Ng, M.; Biggar, W.D. Effect of cyclic adenosine 3',5'-monophosphate antagonists 
on endotoxin-induced inhibition of human neutrophil chemotaxis. Infect. Immun.  1979,  24,  
434–440. 
129.  Rivkin, I.; Rosenblatt, J.; Becker, E.L. The role of cyclic AMP in the chemotactic responsiveness 
and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement 
and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and 
cholera toxin. J. Immunol. 1975, 115, 1126–1134. 
130.  Smits, H.H.; Gloudemans, A.K.; van Nimwegen, M.; Willart, M.A.; Soullié, T.; Muskens, F.; de 
Jong, E.C.; Boon, L.; Pilette, C.; Johansen, F.E.; Hoogsteden, H.C.; Hammad, H.; Lambrecht, 
B.N. Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. 
Mucosal. Immunol. 2009, 2, 331–339.  
131.  Negri, D.R.; Pinto, D.; Vendetti, S.; Patrizio, M.; Sanchez, M.; Riccomi, A.; Ruggiero, P.; Del 
Giudice, G.; De Magistris, M.T. Cholera toxin and Escherichia coli heat-labile enterotoxin, but 
not their nontoxic counterparts, improve the antigen-presenting cell function of human B 
lymphocytes. Infect. Immun. 2009, 77, 1924–1935.  
132.  Sun, J.B.; Flach C.F.; Czerkinsky, C.; Holmgren, J. B lymphocytes promote expansion of 
regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B 
subunit. J. Immunol. 2008, 181, 8278–8287. 
133.  Jayasekera, C.R.; Harris, J.B.; Bhuiyan, S.; Chowdhury, F.; Khan, A.I.; Faruque, A.S.; Larocque, 
R.C.; Ryan, E.T.; Ahmed, R.; Qadri, F.; Calderwood, S.B. Cholera toxin-specific memory B cell 
responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J. 
Infect. Dis. 2008, 198, 1055–1061. 
134.  Kataoka, K.; Fujihashi, K.; Sekine, S.; Fukuiwa, T.; Kobayashi, R.; Suzuki, H.; Nagata, H.; 
Takatsu, K.; Shizukuishi, S.; McGhee, J.R.; Fujihashi, K. Nasal cholera toxin elicits IL-5 and  
IL-5 receptor alpha-chain expressing B-1a B cells for innate mucosal IgA antibody responses. J. 
Immunol. 2007, 178, 6058–6065.  
135.  Arce, S.; Nawar, H.F.; Muehlinghaus, G.; Russell, M.W.; Connell, T.D. In vitro induction of 
immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell 
help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis. 
Infect. Immun. 2007, 75, 1413–1423.  
136.  Arce, S.; Nawar, H.F.; Russell, M.W.; Connell, T.D. Differential binding of Escherichia coli 
enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, 
and activation of lymphoid cells. Infect. Immun. 2005, 73, 2718–2727. 
137.  Shreedhar, V.K.; Kelsall, B.L.; Neutra, M.R. Cholera toxin induces migration of dendritic cells 
from the subepithelial dome region to T- and B-cell areas of Peyer's patches. Infect. Immun. 
2003, 71, 504–509. 
138.  Fan, J.L.; Peterson, J.W.; Prabhakar, B.S. Adjuvant effects of cholera toxin b subunit on immune 
response to recombinant thyrotropin receptor in mice. J. Autoimmun. 2000, 14, 43–52. Toxins 2010, 2                 
 
 
446
139.  Miller, J.S.; Cervenka, T.; Lund, J.; Okazaki, I.J.; Moss, J. Purine metabolites suppress 
proliferation of human NK cells through a lineage-specific purine receptor. J. Immunol. 1999, 
162, 7376–7382. 
140.  Iijima, H.; Takahashi, I.; Hiroi, T.; Shimaoka, M.; Kawano, S.; Nagano, K.; Hori, M.; Kiyono, H. 
Orally administered cholera toxin prevents murine intestinal T cells from staphylococcal 
enterotoxin B-induced anergy. Gastroenterology 1998, 115, 1197–1204. 
141.  Benedetti, R.; Lev, P.; Massouh, E.; Fló, J. Long-term antibodies after an oral immunization with 
cholera toxin are synthesized in the bone marrow and may play a role in the regulation of 
memory B-cell maintenance at systemic and mucosal sites. Res. Immunol. 1998, 149, 107–118. 
142.  Kim, P.H.; Eckmann, L.; Lee, W.J.; Han, W.; Kagnoff, M.F. Cholera toxin and cholera toxin B 
subunit induce IgA switching through the action of TGF-beta 1. J. Immunol.  1998,  160,  
1198–1203. 
143.  Sverremark, E.; Fernandez, C. Immunogenicity of bacterial carbohydrates: cholera toxin 
modulates the immune response against dextran B512. Immunology 1997, 92, 153–159. 
144.  Xu-Amano, J.; Jackson, R.J.; Fujihashi, K.; Kiyono, H.; Staats, H.F.; McGhee, J.R. Helper Th1 
and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 
1994, 12, 903–911. 
145.  Xu-Amano, J.; Kiyono, H.; Jackson, R.J.; Staats, H.,F.; Fujihashi K.; Burrows, P.D.; Elson, C.O.; 
Pillai, S.; McGhee, J.R. Helper T cell subsets for immunoglobulin A responses: oral 
immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in 
mucosa associated tissues. J. Exp. Med. 1993, 178, 1309–1320. 
146.  Vajdy, M.; Lycke, N. Stimulation of antigen-specific T- and B-cell memory in local as well as 
systemic lymphoid tissues following oral immunization with cholera toxin adjuvant. Immunology 
1993, 80, 197–203. 
147.  Nilssen, D.E.; Friman, V.; Theman, K.; Björkander, J.; Kilander, A.; Holmgren, J.; Hanson, L.A.; 
Brandtzaeg, P. B-cell activation in duodenal mucosa after oral cholera vaccination in IgA 
deficient subjects with or without IgG subclass deficiency. Scand. J. Immunol.  1993,  38,  
201–208. 
148.  Garrone, P.; Banchereau, J. Agonistic and antagonistic effects of cholera toxin on human B 
lymphocyte proliferation. Mol. Immunol. 1993, 30, 627–635. 
149.  Anastassiou, E.D.; Yamada, H.; Boumpas, D.T.; Tsokos, G.C.; Thyphronitis, G.; Balow, J.; 
Mond, J.J. Cholera toxin promotes the proliferation of anti-mu antibody-prestimulated human B 
cells. Cell. Immunol. 1992, 140, 237–247. 
150.  Dugas, B.; Paul-Eugène, N.; Génot, E.; Mencia-Huerta, J.M.; Braquet, P.; Kolb, J.P. Effect of 
bacterial toxins on human B cell activation. II. Mitogenic activity of the B subunit of cholera 
toxin. Eur. J. Immunol. 1991, 21, 495–500. 
151.  Lycke, N.; Severinson, E.; Strober, W. Cholera toxin acts synergistically with IL-4 to promote 
IgG1 switch differentiation. J. Immunol. 1990, 145, 3316–3324. 
152.  Chen, K.S.; Strober, W. Cholera holotoxin and its B subunit enhance Peyer's patch B cell 
responses induced by orally administered influenza virus: disproportionate cholera toxin 
enhancement of the IgA B cell response. Eur. J. Immunol. 1990, 20, 433–436. Toxins 2010, 2                 
 
 
447
153.  Lycke, N.; Hellström, U.; Holmgren, J. Circulating cholera antitoxin memory cells in the blood 
one year after oral cholera vaccination in humans. Scand. J. Immunol. 1987, 26, 207–211. 
154.  Lee, J.B.; Jang, J.E.; Song, M.K.; Chang, J. Intranasal delivery of cholera toxin induces th17-
dominated T-cell response to bystander antigens. PLoS One 2009, 4, e5190.  
155.  Nyström-Asklin, J.; Adamsson, J.; Harandi, A.M. The adjuvant effect of CpG 
oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of 
immunity against H. pylori in mice. Scand. J. Immunol. 2008, 67, 431–440.  
156.  Huang, C.F.; Wang, C.C.; Wu, T.C.; Chu, C.H.; Peng, H.J. Effect of sublingual administration 
with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera 
toxin on systemic T(H)2 immune responses and mucosal immunity in mice. Ann. Allergy 
Asthma. Immunol. 2007, 99, 443–452. 
157.  Vendetti, S.; Riccomi, A.; Sacchi, A.; Sciaraffia, E.; Gatta, L.; Pioli, C.; De Magistris, M.T. 
Inhibition of T cell proliferation by cholera toxin involves the modulation of costimulatory 
molecules CTLA-4 and CD28. Immunol. Lett. 2008, 115, 59–69.  
158.  Lysaght, J.; Jarnicki, A.G.; Mills, K.H. Reciprocal effects of Th1 and Treg cell inducing 
pathogen-associated immunomodulatory molecules on anti-tumor immunity. Cancer Immunol. 
Immunother. 2007, 56, 1367–1379.  
159.  Su, S.B.; Silver, P.B.; Wang, P.; Chan, C.C.; Caspi, R.R. Cholera toxin prevents Th1-mediated 
autoimmune disease by inducing immune deviation. J. Immunol. 2004, 173, 755–761. 
160.  Wang, M.; Bregenholt, S.; Petersen, J.S. The cholera toxin B subunit directly costimulates 
antigen-primed CD4+ T cells ex vivo. Scand. J. Immunol. 2003, 58, 342–349. 
161.  Lavelle, E.C.; McNeela, E.; Armstrong, M.E.; Leavy, O.; Higgins, S.C.; Mills, K.H. Cholera 
toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating 
dendritic cell activation. J. Immunol. 2003, 171, 2384–2392. 
162.  Staples, K.J.; Bergmann, M.; Tomita, K.; Houslay, M.D.; McPhee, I.; Barnes, P.J.; Giembycz, 
M.A.; Newton, R. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 
from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A. J. 
Immunol. 2001, 167, 2074–2080. 
163.  Pacheco, S.E.; Gibbs, R.A.; Ansari-Lari, A.; Rogers, P. Intranasal immunization with HIV 
reverse transcriptase: effect of dose in the induction of helper T cell type 1 and 2 immunity. AIDS 
Res. Hum. Retroviruses 2000, 16, 2009–2017. 
164.  Eriksson, K.; Nordström, I.; Czerkinsky, C.; Holmgren, J. Differential effect of cholera toxin on 
CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation 
of human naive T cells. Clin. Exp. Immunol. 2000, 121, 283–288. 
165.  Yamamoto, M.; Kiyono, H.; Yamamoto, S.; Batanero, E.; Kweon, M.N.; Otake, S.; Azuma, M.; 
Takeda, Y.; McGhee, J.R. Direct effects on antigen-presenting cells and T lymphocytes explain 
the adjuvanticity of a nontoxic cholera toxin mutant. J. Immunol. 1999, 162, 7015–7021. 
166.  McSorley, S.J.; Rask, C.; Pichot, R.; Julia, V.; Czerkinsky, C.; Glaichenhaus, N. Selective 
tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate. Eur. 
J. Immunol. 1998, 28, 424–432. Toxins 2010, 2                 
 
 
448
167.  Sobel, D.O.; Yankelevich, B.; Goyal, D.; Nelson, D.; Mazumder, A. The B-subunit of cholera 
toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse. Diabetes 1998, 
47, 186–191. 
168.  Marinaro, M.; Boyaka, P.N.; Finkelman, F.D.; Kiyono, H.; Jackson, R.J.; Jirillo, E.; McGhee, 
J.R. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an 
oral vaccine without altering mucosal IgA responses. J. Exp. Med. 1997, 185, 415–427. 
169.  Yankelevich, B.; Soldatenkov V.A.; Hodgson, J.; Polotsky, A.J.; Creswell, K.; Mazumder, A. 
Differential induction of programmed cell death in CD8+ and CD4+ T cells by the B subunit of 
cholera toxin. Cell. Immunol. 1996, 168, 229–234. 
170.  Marinaro, M.; Staats, H.F.; Hiroi, T.; Jackson, R.J.; Coste, M.; Boyaka, P.N.; Okahashi, N.; 
Yamamoto, M.; Kiyono, H.; Bluethmann, H.; Fujihashi, K.; McGhee, J.R. Mucosal adjuvant 
effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. 
Immunol. 1995, 155, 4621–4629. 
171.  Bowen, J.C.; Nair, S.K.; Reddy, R.; Rouse, B.T. Cholera toxin acts as a potent adjuvant for the 
induction of cytotoxic T-lymphocyte responses with non-replicating antigens. Immunology 1994, 
81, 338–342. 
172.  Hörnquist, E.; Lycke, N. Cholera toxin adjuvant greatly promotes antigen priming of T cells. 
Eur. J. Immunol. 1993, 23, 2136–2143. 
173.  Woogen, S.D.; Turo, K.; Dieleman, L.A.; Beagley, K.W.; Elson, C.O. Inhibition of murine T cell 
activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second 
messenger system. J. Immunol. 1993, 150, 3274–3283. 
174.  Valitutti, S.; Dessing, M.; Lanzavecchia, A. Role of cAMP in regulating cytotoxic T lymphocyte 
adhesion and motility. Eur. J. Immunol. 1993, 23, 790–795. 
175.  Maghazachi, A.A. Cholera toxin inhibits interleukin-2-induced, but enhances pertussis toxin-
induced T-cell proliferation: regulation by cyclic nucleotides. Immunology 1992, 75, 103–107. 
176.  Gupta, S.; Shimizu, M.; Ohira, K.; Vayuvegula, B. T cell activation via the T cell receptor: a 
comparison between WT31 (defining alpha/beta TcR)-induced and anti-CD3-induced activation 
of human T lymphocytes. Cell. Immunol. 1991, 132, 26–44. 
177.  Anderson, D.L.; Tsoukas, C.D. Cholera toxin inhibits resting human T cell activation via a 
cAMP-independent pathway. J. Immunol. 1989, 143, 3647–3652. 
178.  Bjorndahl, J.M.; Sung, S.S.; Hansen, J.A.; Fu, S.M. Human T cell activation: differential 
response to anti-CD28 as compared to anti-CD3 monoclonal antibodies. Eur. J. Immunol. 1989, 
19, 881–887. 
179.  Lycke, N.; Bromander, A.K.; Ekman, L.; Karlsson, U.; Holmgren, J. Cellular basis of 
immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in 
vivo. J. Immunol. 1989, 142, 20–27. 
180.  Poggi, A.; Spada, F.; Costa, P.; Tomasello, E.; Revello, V.; Pella, N.; Zocchi, M.R.; Moretta, L. 
Dissection of lymphocyte function-associated antigen 1-dependent adhesion and signal 
transduction in human natural killer cells shown by the use of cholera or pertussis toxin. Eur. J. 
Immunol. 1996, 26, 967–975. Toxins 2010, 2                 
 
 
449
181.  Maghazachi, A.A.; al-Aoukaty, A. Guanine nucleotide binding proteins mediate the chemotactic 
signal of transforming growth factor-beta 1 in rat IL-2 activated natural killer cells. Int. Immunol. 
1993, 5, 825–832. 
182.  Watanabe, M.; Kiyohara, T.; Murata, K.; Yodoi, J.; Itakura, H. Cholera toxin inhibits lethal hit 
stage of natural killer cell-mediated cytotoxicity. Microbiol. Immunol. 1993, 37, 317–323. 
183.  Maghazachi, A.A. Tumor necrosis factor-alpha is chemokinetic for lymphokine-activated killer 
cells: regulation by cyclic adenosine monophosphate. J. Leukoc. Biol. 1991, 49, 302–308. 
184.  Whalen, M.M.; Bankhurst, A.D. Effects of beta-adrenergic receptor activation, cholera toxin and 
forskolin on human natural killer cell function. Biochem. J. 1990, 272, 327–331. 
185.  Hussain, A.; Himeno, K.; Mayumi, H.; Kawamura, I.; Tsuru, S.; Nomoto, K. Immunomodulatory 
effects of cholera toxin in mice. Nat. Immun. Cell. Growth Regul. 1989, 8, 231–244. 
186.  Fuyama, S.; Naiki, M.; Sendo, F. The mechanism of cholera toxin-induced suppression of natural 
killer cytotoxicity. Gann. 1982, 73, 798–804. 
187.  Fuyama, S.; Sendo, F.; Watabe, S.; Seiji, K.; Arai, S. Inhibition of mouse natural killer activity 
by cholera toxin. Gann. 1981, 72, 141–144. 
188.  Anosova, N.G.; Chabot, S.; Shreedhar, V.; Borawski, J.A.; Dickinson, B.L.; Neutra, M.R. 
Cholera toxin, E. coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration 
into the follicle-associated epithelium of Peyer's patches. Mucosal Immunol. 2008, 1, 59–67. 
189.  Feng, B.S.; Zheng, P.Y.; Chen, X.; Liao, X.Q.; Yang, P.C. Investigation of the role of cholera 
toxin in assisting the initiation of the antigen-specific Th2 response. Immunol. Invest. 2008, 37, 
782–797. 
190.  Krishnamoorthy, N.; Oriss, T.B.; Paglia, M.; Fei, M.; Yarlagadda, M.; Vanhaesebroeck, B.; Ray, 
A.; Ray, P. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and 
allergic asthma. Nat. Med. 2008, 14, 565–573. 
191.  Chandy, A.G.; Nurkkala, M.; Josefsson, A.; Eriksson, K. Therapeutic dendritic cell vaccination 
with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to 
complete tumour eradication in mice bearing HPV 16 expressing tumours. Vaccine 2007, 25, 
6037–6046. 
192.  Bimczok, D.; Rau, H.; Wundrack ,N.; Naumann, M.; Rothkötter, H.J.; McCullough, K.; 
Summerfield, A. Cholera toxin promotes the generation of semi-mature porcine monocyte-
derived dendritic cells that are unable to stimulate T cells. Vet. Res. 2007, 38, 597–612. 
193.  Wendland, M.; Czeloth, N.; Mach, N.; Malissen, B.; Kremmer, E.; Pabst, O.; Förster, R. CCR9 is 
a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl. Acad. Sci. 
USA 2007, 104, 6347–6352. 
194.  Isomura, I.; Yasuda, Y.; Tsujimura, K.; Takahashi, T.; Tochikubo, K.; Morita, A. Recombinant 
cholera toxin B subunit activates dendritic cells and enhances antitumor immunity. Microbiol. 
Immunol. 2005, 49, 79–87. 
195.  Bagley, K.C.; Abdelwahab, S.F.; Tuskan, R.G.; Lewis, G.K. Calcium signaling through 
phospholipase C activates dendritic cells to mature and is necessary for the activation and 
maturation of dendritic cells induced by diverse agonists. Clin. Diagn. Lab. Immunol. 2004, 11, 
77–82. Toxins 2010, 2                 
 
 
450
196.  Bagley, K.C.; Abdelwahab, S.F.; Tuskan, R.G.; Fouts, T.R.; Lewis, G.K. Cholera toxin and heat-
labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit 
cytokine production through a cyclic AMP-dependent pathway. Infect. Immun.  2002,  70,  
5533–5539. 
197.  George-Chandy, A.; Eriksson, K.; Lebens, M.; Nordström, I.; Schön, E.; Holmgren, J. Cholera 
toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and 
CD86 expression on antigen-presenting cells. Infect. Immun. 2001, 69, 5716–5725. 
198.   Porgador, A.; Staats, H.F.; Itoh, Y.; Kelsall, B.L. Intranasal immunization with cytotoxic T-
lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of 
peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. Infect. Immun. 
1998, 66, 5876–5881. 
199.  Anjuère, F.; Luci, C.; Lebens, M.; Rousseau D.; Hervouet, C.; Milon, G.; Holmgren, J.; Ardavin, 
C.; Czerkinsky, C. In vivo adjuvant-induced mobilization and maturation of gut dendritic cells 
after oral administration of cholera toxin. J. Immunol. 2004, 173, 5103–5111. 
200.  Gagliardi, M.C.; De Magistris, MT. Maturation of human dendritic cells induced by the adjuvant 
cholera toxin: role of cAMP on chemokine receptor expression. Vaccine 2003, 21, 856–861. 
201.  Jank, T.; Giesemann, T.; Aktories, K. Rho-glucosylating Clostridium difficile toxins A and B: 
new insights into structure and function. Glycobiology 2007, 17, 15–22. 
202.  Sandvig, K.; Spilsberg, B.; Lauvrak, S.U.; Torgersen, M.L.; Iversen, T.G.; van Deurs, B. 
Pathways followed by protein toxins into cells. Int. J. Med. Microbiol. 2004, 293, 483–490. 
203.  Schirmer, J.; Aktories, K. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating 
toxins. Biochim. Biophys. Acta 2004, 1673, 66–74. 
204.  Genth, H.; Dreger, S.C.; Huelsenbeck, J.; Just, I. Clostridium difficile toxins: more than mere 
inhibitors of Rho proteins. Int. J. Biochem. Cell. Biol. 2008, 40, 592–597. 
205.  Van Hamme, E.; Dewerchin, H.L.; Cornelissen, E.; Verhasselt, B.; Nauwynck, H.J. Clathrin- and 
caveolae-independent entry of feline infectious peritonitis virus in monocytes depends on 
dynamin. J. Gen.Virol. 2008, 89, 2147–2156. 
206.  Ausiello, C.M.; Cerquetti, M.; Fedele, G.; Spensieri, F.; Palazzo, R.; Nasso, M.; Frezza, S.; 
Mastrantonio, P. Surface layer proteins from Clostridium difficile induce inflammatory and 
regulatory cytokines in human monocytes and dendritic cells. Microbes Infect.  2006,  8,  
2640–2646. 
207.  Harokopakis, E.; Albzreh, M.H.; Martin, M.H.; Hajishengallis, G. TLR2 transmodulates 
monocyte adhesion and transmigration via Rac1- and PI3K-mediated inside-out signaling in 
response to Porphyromonas gingivalis fimbriae. J. Immunol. 2006, 176, 7645–7656. 
208.  Methe, H.; Kim, J.O.; Kofler, S.; Nabauer, M.; Weis, M. Statins decrease Toll-like receptor 4 
expression and downstream signaling in human CD14+ monocytes. Arterioscler. Thromb. Vasc. 
Biol. 2005, 25, 1439–1445. 
209.  Warny, M.; Keates, A.C.; Keates, S.; Castagliuolo, I.; Zacks, J.K.; Aboudola, S.; Qamar, A.; 
Pothoulakis, C.; LaMont, J.T.; Kelly, C.P. p38 MAP kinase activation by Clostridium difficile 
toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J. Clin. Invest. 2000, 105, 
1147–1156. Toxins 2010, 2                 
 
 
451
210.  Jefferson, K.K.; Smith, M.F., Jr.; Bobak, D.A. Roles of intracellular calcium and NF-kappa B in 
the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human 
monocytes. J. Immunol. 1999, 163, 5183–5191. 
211.  Hmama, Z.; Knutson, K.L.; Herrera-Velit, P.; Nandan, D.; Reiner, N.E. Monocyte adherence 
induced by lipopolysaccharide involves CD14, LFA-1, and cytohesin-1. Regulation by Rho and 
phosphatidylinositol 3-kinase. J. Biol. Chem. 1999, 274, 1050–1057. 
212.  Linevsky, J.K.; Pothoulakis, C.; Keates, S.; Warny, M.; Keates, A.C.; Lamont, J.T.; Kelly, C.P. 
IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes. 
Am. J. Physiol. 1997, 273, 1333–1340. 
213.  Souza, M.H.; Melo-Filho, A.A.; Rocha, M.F.; Lyerly, D.M.; Cunha, F.Q.; Lima, A.A.; Ribeiro, 
R.A. The involvement of macrophage-derived tumour necrosis factor and lipoxygenase products 
on the neutrophil recruitment induced by Clostridium difficile toxin B. Immunology 1997, 91, 
281–288. 
214.  Siffert, J.C.; Baldacini, O.; Kuhry, J.G.; Wachsmann, D.; Benabdelmoumene, S.; Faradji, A.; 
Monteil, H.; Poindron, P. Effects of Clostridium difficile toxin B on human monocytes and 
macrophages: possible relationship with cytoskeletal rearrangement. Infect. Immun. 1993, 61, 
1082–1090. 
215.  Flegel, W.A.; Müller, F.; Däubener, W.; Fischer, H.G.; Hadding, U.; Northoff, H. Cytokine 
response by human monocytes to Clostridium difficile toxin A and toxin B. Infect. Immun. 1991, 
59, 3659–3666. 
216.  Kang, J.H.; Lee, G.S.; Jeung, E.B.; Yang, M.P. Trans-10, cis-12 conjugated linoleic acid 
modulates phagocytic responses of canine peripheral blood polymorphonuclear neutrophilic 
leukocytes exposed to Clostridium difficile toxin B. Vet. Immunol. Immunopathol. 2009, 130, 
178–186. 
217.  Lee, J.Y.; Kim, H.; Cha, M.Y.; Park, H.G.; Kim, Y.J.; Kim, I.Y.; Kim, J.M. Clostridium difficile 
toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, 
and the NF-kappaB signaling pathway. J. Mol. Med. 2009, 87, 169–180. 
218.  El Bekay, R.; Alba, G.; Reyes, M.E.; Chacón, P.; Vega, A.; Martín-Nieto, J.; Jiménez, J.; Ramos, 
E.; Oliván, J.; Pintado, E.; Sobrino, F. Rac2 GTPase activation by angiotensin II is modulated by 
Ca2+/calcineurin and mitogen-activated protein kinases in human neutrophils. J. 
Mol.Endocrinol. 2007, 39, 351–363. 
219.  Brito, G.A.; Sullivan, G.W.; Ciesla, W.P., Jr.; Carper, H.T.; Mandell, G.L.; Guerrant, R.L. 
Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. J. 
Infect. Dis. 2002, 185, 1297–1306. 
220.  Servant, G.; Weiner, O.D.; Herzmark, P.; Balla, T.; Sedat, J.W.; Bourne, H.R. Polarization of 
chemoattractant receptor signaling during neutrophil chemotaxis. Science 2000, 287, 1037–1040. 
221.  Däubener, W.; Leiser, E.; von Eichel-Streiber, C.; Hadding, U. Clostridium difficile toxins A and 
B inhibit human immune response in vitro. Infect. Immun. 1988, 56, 1107–1112. 
222.  Dailey, D.C.; Kaiser, A.; Schloemer, R.H. Factors influencing the phagocytosis of Clostridium 
difficile by human polymorphonuclear leukocy tes. Infect. Immun. 1987, 55, 1541–1546. 
223.  Yanagawa, Y.; Onoé, K. CCL19 induces rapid dendritic extension of murine dendritic cells. 
Blood 2002, 100, 1948–1956. Toxins 2010, 2                 
 
 
452
224.  Garrett, W.S.; Chen, L.M.; Kroschewski, R.; Ebersold, M.; Turley, S.; Trombetta, S.; Galán, J.E.; 
Mellman, I. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 2000, 102, 
325–334. 
225.  West, M.A.; Prescott, A.R.; Eskelinen, E.L.; Ridley, A.J.; Watts, C. Rac is required for 
constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr. 
Biol. 2000, 10, 839–848. 
226.  Malorni, W.; Paradisi, S.; Dupuis, M.L.; Fiorentini, C.; Ramoni, C. Enhancement of cell-
mediated cytotoxicity by Clostridium difficile toxin A: an in vitro study. Toxicon  1991,  29,  
417–428. 
© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. 
This article is an open-access article distributed under the terms and conditions of the Creative 
Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). 